FORMULATION OF NUCLEIC ACIDS AND ACEMANNAN

The present invention is related to the medical field, and in particular to the use of new formulations of adjuvants with vaccine antigens. The technical object of the invention is the development of formulations which are capable of potentiating the immune response of the organism to vaccines of nu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	IGLESIAS PEREZ, ENRIQUE, GUILLEN NIETO, GERARDO ENRIQUE, PICHARDO DIAZ, DAGMARA, SANDEZ OQUENDO, BELQUIS, LEAL ANGULO, MARIA DE JESUS, MUZIO GONZALEZ, VERENA LUCILA, AGUILAR RUBIDO, JULIO CESAR, QUINTANA VAZQUEZ, DIOGENES, CROMBET MENENDEZ, LISSETE, MUSACCHIO LASA, ALEXIS, HERRERA BUCH, ANTONIETA, PENTON ARIAS, EDUARDO
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is related to the medical field, and in particular to the use of new formulations of adjuvants with vaccine antigens. The technical object of the invention is the development of formulations which are capable of potentiating the immune response of the organism to vaccines of nucleic acids. In order to attain this objective, a formulation has been developed which contains as fundamental components the vaccine nucleic acid and acemannan in adequate proportions, in addition to stabilizing and preservative agents. The formulations of the invention are applicable to the pharmaceutical industry as vaccine formulations both for human and animal use.